Abstract
Conclusions and Relevance IDH mutation is a central and defining event in the development and progression of glioma and may be a key target for future therapies for these types of neoplasms.
Original language | English |
---|---|
Pages (from-to) | 1319-1325 |
Number of pages | 7 |
Journal | JAMA Neurology |
Volume | 71 |
Issue number | 10 |
DOIs | |
Publication status | Published - 1 Oct 2014 |